îæ€çŽ¢
îæ€çŽ¢
î
LAVA Therapeutics NV
LVTXîãŠã©ãããªã¹ãã«è¿œå
1.740USD
0.0000.00%
çµå€Â 05/15, 16:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
45.77Mæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
î
詳现æ å ± LAVA Therapeutics NV äŒæ¥å
LAVA Therapeutics NV, formerly known as Lava Therapeutics BV, is a provider of biotechnology research and development services based in the Netherlands. The Company focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.
LAVA Therapeutics NVã®äŒæ¥æ å ±
îäŒæ¥ã³ãŒãLVTX
äŒç€ŸåLAVA Therapeutics NV
äžå Žæ¥Mar 25, 2021
æé«çµå¶è²¬ä»»è
ãCEOãMr. Stephen A. Hurly
åŸæ¥å¡æ°34
蚌åžçš®é¡Ordinary Share
決ç®ææ«Mar 25
æ¬ç€Ÿæåšå°Yalelaan 60
éœåžUTRECHT
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœNetherlands
éµäŸ¿çªå·3584 CM
é»è©±çªå·31850163100
ãŠã§ããµã€ãhttps://www.lavatherapeutics.com/
äŒæ¥ã³ãŒãLVTX
äžå Žæ¥Mar 25, 2021
æé«çµå¶è²¬ä»»è
ãCEOãMr. Stephen A. Hurly
LAVA Therapeutics NVã®çµå¶é£
îäŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Dr. Kapil Dhingra, M.D.
Dr. Kapil Dhingra, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
--
-100.00%
Mr. Erik J. Van Den Berg
Mr. Erik J. Van Den Berg
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Joel Jean-Mairet, Ph.D.
Mr. Joel Jean-Mairet, Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Ms. Nanna L. Lueneborg, Ph.D.
Ms. Nanna L. Lueneborg, Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Mr. Stefan Luzi
Mr. Stefan Luzi
Non-Executive Director
Non-Executive Director
--
--
Dr. Guido Magni, M.D., Ph.D.
Dr. Guido Magni, M.D., Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Ms. Karen J. Wilson, CPA
Ms. Karen J. Wilson, CPA
Non-Executive Independent Director
Non-Executive Independent Director
--
-100.00%
Mr. Edward F. Smith
Mr. Edward F. Smith
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Benjamin Winograd, M.D., Ph.D.
Mr. Benjamin Winograd, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Paul W.H.I. Parren
Dr. Paul W.H.I. Parren
Executive Vice President Head of Research and Development
Executive Vice President Head of Research and Development
--
--
詳现ãèŠã
äŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Dr. Kapil Dhingra, M.D.
Dr. Kapil Dhingra, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
--
-100.00%
Mr. Erik J. Van Den Berg
Mr. Erik J. Van Den Berg
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Joel Jean-Mairet, Ph.D.
Mr. Joel Jean-Mairet, Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Ms. Nanna L. Lueneborg, Ph.D.
Ms. Nanna L. Lueneborg, Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Mr. Stefan Luzi
Mr. Stefan Luzi
Non-Executive Director
Non-Executive Director
--
--
Dr. Guido Magni, M.D., Ph.D.
Dr. Guido Magni, M.D., Ph.D.
Non-Executive Director
Non-Executive Director
--
--
åçå èš³
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
äºæ¥å¥
å°åå¥
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
æ ªäž»
æŽæ°æå»: Fri, Nov 21
æŽæ°æå»: Fri, Nov 21
æ ªäž»çµ±èš
çš®é¡
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Shay Capital LLC
9.69%
Redmile Group, LLC
7.89%
BML Capital Management LLC
7.49%
Sanofi SA
7.30%
Merck & Co Inc
4.37%
ä»ã®
63.27%
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Shay Capital LLC
9.69%
Redmile Group, LLC
7.89%
BML Capital Management LLC
7.49%
Sanofi SA
7.30%
Merck & Co Inc
4.37%
ä»ã®
63.27%
çš®é¡
æ ªäž»çµ±èš
æ¯ç
Corporation
3.86%
Individual Investor
0.86%
ä»ã®
95.28%
æ©é¢æè³å®¶ä¿ææ ª
îæŽæ°æå»: Thu, Jan 1
æŽæ°æå»: Thu, Jan 1
å ±åæé
æ©é¢æè³å®¶æ°
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
2025Q4
49
7.26M
27.59%
-4.78M
2025Q3
45
7.48M
28.43%
-4.70M
2025Q2
48
18.32M
69.64%
-2.74M
2025Q1
59
22.25M
84.60%
-1.27M
2024Q4
61
18.80M
71.50%
-11.80K
2024Q3
56
15.93M
60.60%
-3.34M
2024Q2
58
16.07M
61.13%
-4.19M
2024Q1
58
16.06M
61.10%
-4.38M
2023Q4
51
18.10M
68.85%
+283.15K
2023Q3
52
18.00M
68.48%
-418.56K
詳现ãèŠã
æ ªäž»åå
îäŒç€Ÿå
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
å€åç
æ¥ä»
Shay Capital LLC
--
0%
-2.55M
-100.00%
Redmile Group, LLC
--
0%
-2.07M
-100.00%
BML Capital Management LLC
--
0%
-1.97M
-100.00%
Cooperatieve Gilde Healthcare IV UA
--
0%
-4.41M
-100.00%
Hurly (Stephen A.)
--
0%
-5.00K
-100.00%
詳现ãèŠã
é¢é£ETF
îæŽæ°æå»: Sat, Dec 6
æŽæ°æå»: Sat, Dec 6
éæå
æ¯ç
AltShares Event-Driven ETF
0%
AltShares Event-Driven ETF
æ¯ç0%
é åœé
îéå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã
æ¥ä»
é
åœé
æš©å©ç¢ºå®æ¥
æ¯ææ¥
é
åœèœã¡æ¥
ããŒã¿ãªã
æ ªåŒåå²
îæ¥ä»
é
åœèœã¡æ¥
çš®é¡
æ¯ç
ããŒã¿ãªã
æ¥ä»
é
åœèœã¡æ¥
çš®é¡
æ¯ç
ããŒã¿ãªã
